Rhythm Pharmaceuticals, Inc. (RYTM)
113.81
-0.13
(-0.11%)
USD |
NASDAQ |
Nov 10, 16:00
113.81
0.00 (0.00%)
After-Hours: 20:00
Rhythm Pharmaceuticals Cash from Operations (Annual) : -115.68M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -115.68M |
| December 31, 2024 | -113.88M |
| December 31, 2023 | -136.16M |
| December 31, 2022 | -173.43M |
| December 31, 2021 | -146.00M |
| December 31, 2020 | -121.98M |
| December 31, 2019 | -122.75M |
| Date | Value |
|---|---|
| December 31, 2018 | -62.06M |
| December 31, 2017 | -29.46M |
| December 31, 2016 | -23.22M |
| December 31, 2015 | -6.752M |
| December 31, 2014 | -7.508M |
| December 31, 2013 | -19.16M |
| December 31, 2012 | -17.83M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| BioMarin Pharmaceutical, Inc. | 827.99M |
| Cytokinetics, Inc. | -510.01M |
| Exelixis, Inc. | 884.27M |
| Ionis Pharmaceuticals, Inc. | -268.58M |